Skip to content

The Role of Exercise in the Treatment of PTSD Symptoms

The Role of Exercise in the Treatment of PTSD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02649127
Enrollment
72
Registered
2016-01-07
Start date
2011-02-28
Completion date
2017-05-31
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder

Keywords

exercise, biomarker

Brief summary

This is an 8-week experimental, repeated-measures clinical trial randomizing 120 Service Members with symptoms of PTSD into one of four groups: 1) imaginal exercises of exposure therapy only, 2) aerobic exercise only, 3) imaginal exercises augmented with aerobic exercise, or 4) self-care.

Detailed description

One of the signature injuries of combat operations following 9/11 is posttraumatic stress disorder (PTSD). The most effective treatment for PTSD is exposure therapy where, under the supervision of a trained therapist, individuals are exposed to prolonged and repeated imagined images of the trauma until the images no longer cause severe anxiety. Various forms of exercise have been used to treat a broad range of depression and anxiety disorders and exercise has been used with some success to treat individuals with PTSD. Considering the population of otherwise healthy and physically active Service Members suffering from symptoms of PTSD, it seems possible that exercise might serve as an outlet for the emotional reactions experienced during therapy, decreasing emotional distress, and increasing the individual's tolerance to imaginal exposure serving as a powerful adjunct to exposure therapy. The purpose of this study to explore the role of exercise in the treatment of symptoms of posttraumatic stress disorder (PTSD), specifically determining if the efficacy of imaginal exercises, part of exposure therapy for PTSD, can be improved by augmenting the therapy with aerobic exercise. Towards this end, this 8-week experimental, repeated-measures clinical trial will randomize 120 Service Members with symptoms of PTSD into one of four groups: 1) imaginal exercises of exposure therapy only, 2) aerobic exercise only, 3) imaginal exercises augmented with aerobic exercise, or 4) self-care.

Interventions

BEHAVIORALimaginal therapy

imaginal exercise of Prolonged Exposure therapy

BEHAVIORALexercise

aerobic training at a frequency of a minimum of 3 sessions per week, at vigorous intensity \[i. e., \>60% of oxygen uptake reserve (VO2R)\], and a time of 20-25 minutes each bout of training

BEHAVIORALself-care

meeting with a nurse to review and discuss publically available written materials that outline approaches for dealing with posttraumatic stress symptoms

Sponsors

C.R.Darnall Army Medical Center
CollaboratorFED
The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* be an Active Duty, Reserve, or National Guard Army, Air Force, Navy, or Marine Veteran of Operation Iraqi Freedom (OIF) / Operation Enduring Freedom (OEF) eligible for military medical care * be at least 18 years old * be able to read and speak English * answer no to the seven questions of the Physical Activity Readiness Questionnaire (PAR-Q), or have primary care provider approval to undertake an exercise program. * score ≥25 on the PTSD CheckList - Stressor-Specific(PCL-S); participants scoring \>50 on the PCL-S will be contacted weekly to ensure that their symptoms are under control and they do not require a higher level of care. * report on the PTSD Symptom Scale - Interview (PSS-I) an exposure to a traumatic event (Criterion A), at least one re-experiencing symptom (Criterion B), and at least one avoidance symptom (Criterion C) * participants taking psychotropic medications agree to work with their prescriber to remain on stable doses of any prescribed psychotropic medications for the duration of the intervention and through the 1-month follow-up assessment as much as possible and as medically indicated * anticipate being in the area for at least three months to complete intervention and 13-week follow-up assessment

Exclusion criteria

* score \<25 on the PTSD CheckList - Stressor Specific (PCL-S) (Those scoring \<25 do not have enough symptom severity to adequately test the study hypotheses * have undergone exposure therapy for PTSD within the last year * be taking benzodiazepines every day on a prescribed schedule (Individuals prescribed and taking a benzodiazepine only as needed will not be excluded.) * suicidal ideation with moderate to severe intent warranting intervention * active psychosis or mania * be on a medical profile that prohibits exercise

Design outcomes

Primary

MeasureTime frameDescription
PTSD symptoms as assessed using the PTSD Symptom Scale - Interview (PSS-I) and PTSD CheckList (PCL)change in score between baseline, 1-week post-treatment, 1-month post-treatment, 6-months post-treatmentdegree of PTSD symptoms

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026